Beneficiaries will be residents of Kangemi, one of Nairobi’s poorest districts, who are volunteers in the Kenya AIDS Vaccine Initiative’s quest for the ultimate solution to the AIDS pandemic: a vaccine to prevent HIV infection. Transportation is severely lacking in Kangemi. For residents who volunteer for clinical trials of a vaccine developed by the Universities of Oxford and Nairobi, getting to the clinic is a major obstacle. KAVI urgently needs a van and driver for these volunteers.
KAVI scientists have identified a clinic at Kangemi as one of the sites where testing will be conducted to test correct dosages and the level of immune response of this vaccine concept.
Providing transportation for trial volunteers will greatly ease their burden and will help ensure that the vaccine trials are concluded as rapidly as possible.